SM
Schmertzler Michael
董事
BoardM
内部人交易记录
董事尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Schmertzler Michael, 董事. Director active across 2 companies, notably PTC Therapeutics, INC.. Aggregated, 22 disclosures have been logged. Breakdown: 0 buy · 14 sells. Total volume traded: €4.3m. History available since 7 January 2022. The latest transaction was filed on 9 September 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Schmertzler Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报22 总计
9,428 股@ US$67.79Common StockSEC:0001288952-26-000008:0
572 股@ US$68.67Common StockSEC:0001288952-26-000008:1
10,000 股@ US$67.34Common StockSEC:0001288952-26-000008:2
6,874 股@ US$72.740.0081% mcap11.2% 占其流量Common StockSEC:0001288952-26-000006:0
5,626 股@ US$73.180.0067% mcap9.3% 占其流量Common StockSEC:0001288952-26-000006:1
11,890 股@ US$71.550.014% mcap19.1% 占其流量Common StockSEC:0001288952-26-000006:2
610 股@ US$72.220.0007% mcap1.0% 占其流量Common StockSEC:0001288952-26-000006:3
5,335 股@ US$72.860.0067% mcap14.8% 占其流量Common StockSEC:0001288952-26-000004:0
7,165 股@ US$73.670.0091% mcap20.1% 占其流量Common StockSEC:0001288952-26-000004:1
9,419 股@ US$70.780.011% mcap25.2% 占其流量Common StockSEC:0001288952-26-000004:2
2,390 股@ US$71.880.0029% mcap6.5% 占其流量Common StockSEC:0001288952-26-000004:3
691 股@ US$72.920.0009% mcap1.9% 占其流量Common StockSEC:0001288952-26-000004:4
8,000 股0Common StockSEC:0001288952-26-000002:0
24,000 股@ US$30.8688.7% 占其流量Common StockSEC:0001288952-25-000004:0
25,005 股@ US$0.00118.2% 占其流量Class B Common StockSEC:0001433642-25-000096:0
100,000 股@ US$0.001100.0% 占其流量Class B Common StockSEC:0001628280-25-005774:0
8,000 股0Common StockSEC:0001415889-25-001022:0
8,000 股0Common StockSEC:0001415889-24-004133:0
1,500 股@ US$27.8147.6% 占其流量Common StockSEC:0001415889-24-000919:0
1,000 股@ US$44.8652.4% 占其流量Common StockSEC:0001415889-23-009501:0
8,000 股0Common StockSEC:0001415889-23-000682:0
6,400 股0Common StockSEC:0001179110-22-000391:0
About Schmertzler Michael
SCHMERTZLER MICHAEL is Administrateur at PTC Therapeutics, INC. and is also linked to Hamilton Lane INC. He has 10 filings in total, and across the sampled filings from 2022-01-11 to 2026-01-06, the reported volume is EUR 80019 of sales and EUR 0 of purchases, with the modal transaction nature listed as Attribution.